The selection of patients. Based on currently available data Committee recommends that the treatment of ribavirin aerosol following categories of infants hospitalized with diseases of the lower divisions of the respiratory tract caused by respiratory syncytial virus.
1. Children are a high risk of tazheloy or complicated respiratory syncytial virus. This includes children with congenital heart disease, bronchitis, pulmonalnoy dysplasia and other chronic diseases and premature children. In addition, a group of high risk of complications in respiratory syncytial virus infections are children with immunodeficiency (especially with severe combined immunodeficiency), recent transplant recipients and receiving chemotherapy for the malignant tumors.
2. Ill infants hospitalized with respiratory syncytial virus lower divisions of the respiratory tract. Because of the severity often difficult to assess the clinical status of children with respiratory syncytial virus, and therefore it is necessary to the content of gases in the blood. Children with a value of R02 arterial blood less than 65 mm Hg and the increasing level of RS02 arterial blood should be considered candidates for the treatment of ribavirin. As Non-invasive method for determining arterial blood oxygen saturation can be used oximeter.
3. To be treatment for infants under the age of 6 weeks and was hospitalized with the defeat of the lower divisions of the respiratory tract, if there is a tendency to complications during or children whose prolonged period of illness compounded by the associated conditions such as multiple congenital anomalies or sensitive and metabolic diseases.